Viewing SEC Facts Units
Company Name:
Revance Therapeutics, Inc.
CIK:
1479290
Start Filing Date:
2016-01-01
End Filing Date:
2016-03-31
ACCN:
0001479290-16-000039
Value:
$ 28,005,611
Value Error:
$ None
Created By:
Date Filed:
2016-05-10
FY:
2016
Fiscal Period:
Q1
Frame:
CY2016Q1
Type:
us-gaap
Form:
10-Q
Units:
shares